Arrowstreet Capital Limited Partnership bought a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 13,454 shares of the company’s stock, valued at approximately $306,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in SGRY. Voya Investment Management LLC purchased a new position in shares of Surgery Partners in the 2nd quarter worth about $222,000. American International Group Inc. lifted its stake in shares of Surgery Partners by 7.1% in the 1st quarter. American International Group Inc. now owns 11,462 shares of the company’s stock valued at $224,000 after acquiring an additional 759 shares during the last quarter. Royal Bank of Canada lifted its stake in shares of Surgery Partners by 680.5% in the 2nd quarter. Royal Bank of Canada now owns 10,544 shares of the company’s stock valued at $240,000 after acquiring an additional 9,193 shares during the last quarter. Atria Investments LLC lifted its stake in shares of Surgery Partners by 2.3% in the 2nd quarter. Atria Investments LLC now owns 10,627 shares of the company’s stock valued at $242,000 after acquiring an additional 238 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in Surgery Partners during the 1st quarter valued at approximately $244,000. Institutional investors own 37.28% of the company’s stock.
Shares of Surgery Partners, Inc. (SGRY) traded down $0.15 during trading on Friday, reaching $9.45. The company had a trading volume of 545,000 shares, compared to its average volume of 321,915. Surgery Partners, Inc. has a one year low of $7.10 and a one year high of $24.05. The company has a market cap of $468.18, a PE ratio of 64.00 and a beta of 1.92. The company has a current ratio of 1.89, a quick ratio of 1.73 and a debt-to-equity ratio of 5.69.
In other Surgery Partners news, major shareholder H.I.G. Surgery Centers, Llc sold 26,455,651 shares of the firm’s stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $19.00, for a total transaction of $502,657,369.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 7.60% of the stock is owned by company insiders.
A number of research analysts have commented on SGRY shares. Bank of America Corporation lowered their price target on Surgery Partners from $23.00 to $19.00 and set a “buy” rating for the company in a research report on Monday, October 9th. BidaskClub downgraded Surgery Partners from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Jefferies Group LLC reiterated a “buy” rating and set a $16.00 target price (down previously from $22.00) on shares of Surgery Partners in a report on Friday, September 8th. Zacks Investment Research upgraded Surgery Partners from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 11th. Finally, KeyCorp reiterated a “hold” rating on shares of Surgery Partners in a research note on Friday, September 22nd. Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $18.86.
About Surgery Partners
Surgery Partners, Inc is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.